Clinical trial
Serum Copeptin as Biomarker for Diagnosis and Classification of Polyuric Primary Monosymptomatic Nocturnal Enuresis
NCT07496541 is registered in ClinicalTrials.gov with The Children's Hospital of Zhejiang University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Serum Copeptin as Biomarker for Diagnosis and Classification of Polyuric Primary Monosymptomatic Nocturnal Enuresis
- Lead sponsor
- The Children's Hospital of Zhejiang University School of Medicine
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- March 17, 2026
- Completion date
- January 31, 2029
- Enrollment
- 180 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
copeptin, primary monosymptomatic nocturnal enuresis